Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Ther-Biotic Complete** is a hypoallergenic, broad-spectrum probiotic supplement containing a blend of 12 probiotic species, including various *Lactobacillus*, *Bifidobacterium*, and *Streptococcus thermophilus* strains, delivering 25 billion CFU per capsule (or 100 billion CFU in powder form), in a base of inulin from chicory root. It utilizes proprietary InTactic® technology, a polysaccharide complex from seaweed, to protect the microorganisms from stomach acid, ensuring maximum viability in the intestinal tract. The formula supports comprehensive gut health by promoting a balanced intestinal microbiome, enhancing digestive function, strengthening the intestinal epithelial barrier, producing short-chain fatty acids to nourish enterocytes, defending against undesirable organisms, and bolstering both innate and acquired immunity.[1][2][5][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ther-Biotic Complete.